Ross Muken
Stock Analyst at Evercore ISI Group
(2.80)
# 1,722
Out of 5,115 analysts
48
Total ratings
59.26%
Success rate
5.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $250 → $260 | $210.48 | +23.53% | 10 | Jan 13, 2026 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $75.48 | -7.26% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $180.25 | +33.15% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $133.85 | -2.88% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $53.67 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $214.88 | -68.82% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $144.81 | +72.64% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $578.61 | -61.98% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $8.98 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
Jan 13, 2026
Maintains: Outperform
Price Target: $250 → $260
Current: $210.48
Upside: +23.53%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $75.48
Upside: -7.26%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $180.25
Upside: +33.15%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $133.85
Upside: -2.88%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $53.67
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $214.88
Upside: -68.82%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $144.81
Upside: +72.64%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $578.61
Upside: -61.98%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $8.98
Upside: -